Ad is loading...
CSSCX
Price
$23.49
Change
+$0.37 (+1.60%)
Updated
Nov 25 closing price
DFFVX
Price
$37.63
Change
+$0.54 (+1.46%)
Updated
Nov 25 closing price
Ad is loading...

CSSCX vs DFFVX

Header iconCSSCX vs DFFVX Comparison
Open Charts CSSCX vs DFFVXBanner chart's image
Columbia Small Cap Value I C
Price$23.49
Change+$0.37 (+1.60%)
VolumeN/A
CapitalizationN/A
DFA US Targeted Value I
Price$37.63
Change+$0.54 (+1.46%)
VolumeN/A
CapitalizationN/A
CSSCX vs DFFVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSSCX vs. DFFVX commentary
Nov 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSSCX is a StrongBuy and DFFVX is a Buy.

FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 14.6B vs. CSSCX (1.66B). DFFVX pays higher dividends than CSSCX: DFFVX (1.37) vs CSSCX (0.00). CSSCX was incepted earlier than DFFVX: CSSCX (29 years) vs DFFVX (25 years). CSSCX is a more actively managed with annual turnover of: 72.00 vs. DFFVX (20.00). DFFVX has a lower initial minimum investment than CSSCX: DFFVX (0) vs CSSCX (2000). DFFVX annual gain was more profitable for investors over the last year : 32.12 vs. CSSCX (7.46). DFFVX return over 5 years is better than : 69.48 vs. CSSCX (4.35).
CSSCXDFFVXCSSCX / DFFVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years25 years-
Gain YTD6.19319.31832%
Front LoadN/AN/A-
Min. Initial Investment20000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.66B14.6B11%
Annual Yield % from dividends0.001.37-
Returns for 1 year7.4632.1223%
Returns for 3 years-20.8622.28-94%
Returns for 5 years4.3569.486%
Returns for 10 years-39.5271.88-55%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAT19.070.38
+2.03%
Mattel
GNE16.320.28
+1.75%
GENIE ENERGY Ltd
MDT85.75-0.46
-0.53%
Medtronic plc
CLRB1.57-0.01
-0.63%
Cellectar Biosciences
WSBC36.17-0.28
-0.77%
WesBanco